Skip to content

Is the use of Bupivacaine hydrochloride 0.5% an effective treatment for the relief of chronic plantar fascial pain?

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN86484960
Enrollment
80
Registered
2006-09-29
Start date
2002-02-26
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Musculoskeletal Diseases: Plantar fasciitis Musculoskeletal Diseases Plantar fasciitis

Interventions

It is proposed that 80 subjects presenting with heel Pain that have been referred for Podiatric assessment and intervention will be recruited to the study. Those patients who are diagnosed with plant

Sponsors

Record Provided by the NHSTCT Register - 2006 Update - Department of Health
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: The cohort of patients will be recruited from appropriate referrals received from General Practitioners within Primary Care, and Consultants within the UHB Trust for Podiatric assessment and intervention. Volunteers will be provided with information sheets and informed consent required in writing will be obtained prior to the study. Volunteers will be made aware that their withdrawal form the study at any stage will not adversely affect their future treatment. Inclusion criteria: Patients over 18 years of age with pain over the medial aspect of the heel, and who fulfill the criteria set down by Saxelby et al (1997). The Podiatry Department has access to interpreters if there are issues relating to language problems.

Exclusion criteria

Exclusion criteria: 1. Patients with a known sensitivity to local anesthetics 2. Patents with liver disease 3. Patients with kidney disease 4. Patients with broken skin / skin lesions / infection around the injection site 5. Pregnant women 6. Patients on anti coagulation therapy

Design outcomes

Primary

MeasureTime frame
Not provided at time of registration

Secondary

MeasureTime frame
Not provided at time of registration

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026